Midodrine During Recovery From Septic Shock

• Status: Withdrawn
• Trial end date: 2017-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether midodrine administration decreases duration of intravenous vasopressors and intensive care unit length of stay for patients in septic shock.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Northwell Health
• Treatments: Midodrine

Criteria

Inclusion Criteria:

• admitted to intensive care unit

• diagnosis of septic shock on intravenous vasopressors

• stable/decreasing doses of intravenous vasopressors

• stable/improving organ function

Exclusion Criteria:

• allergy to midodrine

• multiple intravenous vasopressors

• increasing intravenous vasopressor requirements

• worsening organ dysfunction

• severe bradycardia